First Time Loading...
H

Hyperfine Inc
NASDAQ:HYPR

Watchlist Manager
Hyperfine Inc
NASDAQ:HYPR
Watchlist
Price: 0.79 USD -0.89% Market Closed
Updated: May 11, 2024

Intrinsic Value

HYPR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. [ Read More ]

The intrinsic value of one HYPR stock under the Base Case scenario is 0.59 USD. Compared to the current market price of 0.79 USD, Hyperfine Inc is Overvalued by 26%.

Key Points:
HYPR Intrinsic Value
Base Case
0.59 USD
Overvaluation 26%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation Backtest
Hyperfine Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HYPR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Hyperfine Inc

Provide an overview of the primary business activities
of Hyperfine Inc.

What unique competitive advantages
does Hyperfine Inc hold over its rivals?

What risks and challenges
does Hyperfine Inc face in the near future?

Has there been any significant insider trading activity
in Hyperfine Inc recently?

Summarize the latest earnings call
of Hyperfine Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hyperfine Inc.

Provide P/S
for Hyperfine Inc.

Provide P/E
for Hyperfine Inc.

Provide P/OCF
for Hyperfine Inc.

Provide P/FCFE
for Hyperfine Inc.

Provide P/B
for Hyperfine Inc.

Provide EV/S
for Hyperfine Inc.

Provide EV/GP
for Hyperfine Inc.

Provide EV/EBITDA
for Hyperfine Inc.

Provide EV/EBIT
for Hyperfine Inc.

Provide EV/OCF
for Hyperfine Inc.

Provide EV/FCFF
for Hyperfine Inc.

Provide EV/IC
for Hyperfine Inc.

Show me price targets
for Hyperfine Inc made by professional analysts.

What are the Revenue projections
for Hyperfine Inc?

How accurate were the past Revenue estimates
for Hyperfine Inc?

What are the Net Income projections
for Hyperfine Inc?

How accurate were the past Net Income estimates
for Hyperfine Inc?

What are the EPS projections
for Hyperfine Inc?

How accurate were the past EPS estimates
for Hyperfine Inc?

What are the EBIT projections
for Hyperfine Inc?

How accurate were the past EBIT estimates
for Hyperfine Inc?

Compare the revenue forecasts
for Hyperfine Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hyperfine Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hyperfine Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hyperfine Inc compared to its peers.

Compare the P/E ratios
of Hyperfine Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Hyperfine Inc with its peers.

Analyze the financial leverage
of Hyperfine Inc compared to its main competitors.

Show all profitability ratios
for Hyperfine Inc.

Provide ROE
for Hyperfine Inc.

Provide ROA
for Hyperfine Inc.

Provide ROIC
for Hyperfine Inc.

Provide ROCE
for Hyperfine Inc.

Provide Gross Margin
for Hyperfine Inc.

Provide Operating Margin
for Hyperfine Inc.

Provide Net Margin
for Hyperfine Inc.

Provide FCF Margin
for Hyperfine Inc.

Show all solvency ratios
for Hyperfine Inc.

Provide D/E Ratio
for Hyperfine Inc.

Provide D/A Ratio
for Hyperfine Inc.

Provide Interest Coverage Ratio
for Hyperfine Inc.

Provide Altman Z-Score Ratio
for Hyperfine Inc.

Provide Quick Ratio
for Hyperfine Inc.

Provide Current Ratio
for Hyperfine Inc.

Provide Cash Ratio
for Hyperfine Inc.

What is the historical Revenue growth
over the last 5 years for Hyperfine Inc?

What is the historical Net Income growth
over the last 5 years for Hyperfine Inc?

What is the current Free Cash Flow
of Hyperfine Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hyperfine Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyperfine Inc

Current Assets 88.9m
Cash & Short-Term Investments 75.2m
Receivables 4.1m
Other Current Assets 9.6m
Non-Current Assets 5.3m
PP&E 3m
Other Non-Current Assets 2.3m
Current Liabilities 8.8m
Accounts Payable 1.2m
Accrued Liabilities 5.4m
Other Current Liabilities 2.1m
Non-Current Liabilities 1m
Other Non-Current Liabilities 1m
Efficiency

Earnings Waterfall
Hyperfine Inc

Revenue
11m USD
Cost of Revenue
-6.3m USD
Gross Profit
4.8m USD
Operating Expenses
-52.9m USD
Operating Income
-48.1m USD
Other Expenses
3.9m USD
Net Income
-44.2m USD

Free Cash Flow Analysis
Hyperfine Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

HYPR Profitability Score
Profitability Due Diligence

Hyperfine Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative Operating Income
Negative Net Income
24/100
Profitability
Score

Hyperfine Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

HYPR Solvency Score
Solvency Due Diligence

Hyperfine Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Hyperfine Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HYPR Price Targets Summary
Hyperfine Inc

Wall Street analysts forecast HYPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYPR is 1.33 USD with a low forecast of 1.01 USD and a high forecast of 1.68 USD.

Lowest
Price Target
1.01 USD
28% Upside
Average
Price Target
1.33 USD
68% Upside
Highest
Price Target
1.68 USD
113% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

HYPR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

HYPR Price
Hyperfine Inc

1M 1M
-21%
6M 6M
-31%
1Y 1Y
-45%
3Y 3Y
-92%
5Y 5Y
-92%
10Y 10Y
-92%
Annual Price Range
0.79
52w Low
0.79
52w High
3.17
Price Metrics
Average Annual Return -57.51%
Standard Deviation of Annual Returns 44.18%
Max Drawdown -94%
Shares Statistics
Market Capitalization 56.8m USD
Shares Outstanding 71 950 000
Percentage of Shares Shorted 2.32%

HYPR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Hyperfine Inc

Country

United States of America

Industry

Health Care

Market Cap

56.8m USD

Dividend Yield

0%

Description

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.

Contact

CONNECTICUT
Guilford
351 New Whitfield Street
+18667966767
https://hyperfine.io/

IPO

2021-01-27

Employees

136

Officers

Executive Chairman
Mr. R. Scott Huennekens CPA, M.B.A.
CEO, President & Director
Ms. Maria Sainz
Founder & Vice Chairman
Dr. Jonathan M. Rothberg Ph.D.
Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary
Mr. Brett Hale
Chief Operating Officer
Dr. Thomas Teisseyre Ph.D.
Vice President of Scientific Affairs
Mr. Chip Truwit FACR, M.D.

See Also

Discover More
What is the Intrinsic Value of one HYPR stock?

The intrinsic value of one HYPR stock under the Base Case scenario is 0.59 USD.

Is HYPR stock undervalued or overvalued?

Compared to the current market price of 0.79 USD, Hyperfine Inc is Overvalued by 26%.